logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 16 of 16 Items
Showing 1 - 16 of 16 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Poster

Seasonal malaria chemoprevention coverage survey for children 3 months –8 years in Aweil, South Sudan, 2022

Akem TE, Schramm B, Akeen WW, Singh SN, Adimw M,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Les medicaments de la CPS sous la loupe

Grandesso F, Ouedraogo P, Issakha Diar MS, Hilario JS, Kouassi F,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Journal Article
|
Research

Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, Afghanistan

Klein A, Bastard M, Hemat H, Singh SN, Muniz B,  et al.
2023-08-24 • PLOS Global Public Health
2023-08-24 • PLOS Global Public Health
Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), such as Afghanis...
Journal Article
|
Pre-Print

Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center run by Médecins sans Frontières in Herat, Afghanistan

Klein A, Bastard M, Hemat H, Singh SN, Muniz B,  et al.
2023-02-16 • medRxiv
2023-02-16 • medRxiv
BACKGROUND
Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), s...
Journal Article
|
Commentary

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues

Potet J, Singh SN, Ritmeijer KKD, Sisay K, Alcoba G,  et al.
2022-12-21 • Toxicon: X
2022-12-21 • Toxicon: X
The medical humanitarian organization Médecins Sans Frontières (MSF) provides medical care in more than 70 countries and admits more than 7000 cases of snakebite in its facilities each y...
Conference Material
|
Video

Malaria: prevention is better than cure

Singh SN
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022
Conference Material
|
Poster

Treatment outcomes among drug-resistant children below 10 years treated with newer drugs, in Médecins Sans Frontieres clinic in Mumbai, India

Singh SN, Singh P, Silsarma A, Iyer AS, Galindo MA,  et al.
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022
Conference Material
|
Video

Prevention is better than cure (panel)

Singh SN, Bassat Q, Sondo P, Di Stefano L, Sangma M,  et al.
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022
Journal Article
|
Research

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India

Goyal V, Mahajan R, Pandey K, Singh SN, Singh RS,  et al.
2018-10-22 • PLOS Neglected Tropical Diseases
2018-10-22 • PLOS Neglected Tropical Diseases
BACKGROUND
In 2010, WHO recommended the use of new short-course treatment regimens in kala-azar elimination efforts for the Indian subcontinent. Although phase 3 studies have shown e...
Journal Article
|
Research

Congenital Rubella Syndrome in Fiji, 1995-2010

Singh SN, Bingwor F, Tayler-Smith K, Manzi M, Marks GB
2013-02-03 • Journal of Tropical Medicine
2013-02-03 • Journal of Tropical Medicine
Setting. A nationwide study in Fiji. Objective. To describe the incidence of congenital rubella syndrome (CRS) and its relationship to the incidence of notified cases of rubella in Fiji ...
Journal Article
|
Review

Snakebite envenoming in humanitarian crises and migration: A scoping review and the Médecins Sans Frontières experience

Alcoba G, Potet J, Vatrinet R, Singh SN, Nanclares C,  et al.
2022-03-01 • Toxicon: X
2022-03-01 • Toxicon: X
Snakebite envenoming is a public health concern in many countries affected by humanitarian crises. Its magnitude was recognized internationally but associations between snakebite peaks a...
Journal Article
|
Research

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India

Goyal V, Burza S, Pandey K, Singh SN, Singh RS,  et al.
2019-09-26 • PLOS Neglected Tropical Diseases
2019-09-26 • PLOS Neglected Tropical Diseases
BACKGROUND:
An earlier open label, prospective, non-randomized, non-comparative, multi-centric study conducted within public health facilities in Bihar, India (CTRI/2012/08/002891) ...
Journal Article
|
Research

How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India?

Nagaraka SB, Satyanarayana S, Chadha SS, Kalemane S, Jaju J,  et al.
2011-10-11 • PLOS One
2011-10-11 • PLOS One
SETTING
Seven districts in Andhra Pradesh, South India.

OBJECTIVES
To a) determine treatment outcomes of patients who fail first line anti-TB treatment and are not place...
Journal Article
|
Commentary

New opportunities in tuberculosis prevention: implications for people living with HIV

Gonzalez Fernandez L, Casas EDT, Singh SN, Churchyard GJ, Brigden G,  et al.
2020-01-01 • Journal of the International AIDS Society
2020-01-01 • Journal of the International AIDS Society
INTRODUCTION:
Tuberculosis (TB) is a leading cause of mortality among people living with HIV (PLHIV). An invigorated global END TB Strategy seeks to increase efforts in scaling up T...
Journal Article
|
Commentary

Providing antiretroviral care in conflict settings

Mills EJ, Ford NP, Singh SN, Eyawo O
2009-10-14 • Current HIV/AIDS Reports
2009-10-14 • Current HIV/AIDS Reports
There has been an historic expectation that delivering combination antiretroviral therapy (cART) to populations affected by violent conflict is untenable due to population movement and s...
Journal Article
|
Case Report/Series

Ebola-negative neonates born to Ebola-infected mothers after monoclonal antibody therapy: a case series

Ottoni MP, Ricciardone JD, Nadimpalli A, Singh SN, Katsomya AM,  et al.
2020-12-01 • Lancet Child and Adolescent Health
2020-12-01 • Lancet Child and Adolescent Health
Background
Few fetuses survive childbirth when the mother is positive for Ebola virus, with almost all being miscarried or stillborn, or dying shortly after birth. Before 2019, only...